|
Index of reports
> Life Threatening Events (270)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 270 Next >>
Possible Cytarabine side effects in female
Reported by a physician from Japan on 2012-08-27
Patient: female, weighing 45.8 kg (100.8 pounds)
Reactions: Cerebral Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-12
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Ofatumumab
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-08
Other drugs received by patient: Granisetron; Maglax; Primperan TAB; Rabeprazole Sodium; Orgadrone
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-24
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Subdural Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: 430 milligram
Start date: 2012-08-14
End date: 2012-08-19
Daunorubicin HCL
Start date: 2012-08-14
End date: 2012-08-16
Revlimid
Dosage: 20 milligram
Administration route: Oral
Start date: 2012-08-14
End date: 2012-08-19
Other drugs received by patient: Fraxiparine
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-08-21
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 mg, 2x/day
Indication: Medulloblastoma
Cytarabine
Dosage: 50 mg, cyclic, every other month
Cytarabine
Dosage: 50 mg, cyclic, every other week then monthly
Indication: Medulloblastoma
Etoposide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-20
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United Kingdom on 2012-08-17
Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Multi-Organ Failure, Neutropenic Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Mylotarg
Dosage: 5.3 mg (total dose)
Indication: Acute Myeloid Leukaemia
Start date: 2007-09-20
End date: 2007-09-22
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-16
Patient: female, weighing 7.4 kg (16.3 pounds)
Reactions: Capillary Leak Syndrome, Hepatic Function Abnormal, Respiratory Failure, Disease Progression, Ascites
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 11 mg (40 mg/m2), qdx5
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Cyclophosphamide
Dosage: 80 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Cytarabine
Dosage: 15 mg, od
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-28
End date: 2010-07-28
Cytarabine
Indication: Chemotherapy
Etoposide
Dosage: 28 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-23
End date: 2010-07-27
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 6 mgr, od
Indication: Chemotherapy
Start date: 2010-07-28
End date: 2010-07-28
Prednisolone
Indication: Chemotherapy
Prednisolone
Dosage: 6 mgr, od
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-07-28
End date: 2010-07-28
Other drugs received by patient: Itraconazole; Vancomycin; Dexamethasone; Filgrastim; Teicoplanin; Ciprofloxacin HCL; Ciprofloxacin HCL; Tramadol HCL; Vancomycin; Ceftazidime; Zofran; Vancomycin; Furosemide; Cotrim; Vancomycin; Vitamin K TAB; Cotrim; Itraconazole; Vancomycin; Vancomycin; Omeprazole; Acetaminophen; Ciprofloxacin; Furosemide; Ceftazidime; Furosemide; Omeprazole
Possible Cytarabine side effects in 4 year old female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 4 year old female, weighing 13.7 kg (30.1 pounds)
Reactions: Blood Bilirubin Increased, Hyponatraemia, Hypernatraemia, Caecitis, Hypokalaemia, Hypophosphataemia, Left Ventricular Dysfunction, Cardiac Failure, Ileus, Diarrhoea, Venoocclusive Liver Disease, Hypocalcaemia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk, cyclic
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-07-05
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-20
End date: 2012-06-25
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-14
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Cytarabine
Dosage: 170 mg, 1 in 1 day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-09
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United States on 2012-08-14
Patient: 66 year old male
Reactions: Sepsis, Melaena, Decreased Appetite, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3360 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
Daunorubicin HCL
Dosage: 435 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
Sprycel
Dosage: 1200 mg, (total)
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-25
End date: 2012-06-12
Possible Cytarabine side effects in 70 year old male
Reported by a physician from Austria on 2012-08-14
Patient: 70 year old male, weighing 94.0 kg (206.8 pounds)
Reactions: Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 120 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-18
Cytarabine
Dosage: 205 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Etoposide
Dosage: 205 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Idarubicin HCL
Dosage: 24 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-13
Other drugs received by patient: Colidimin; Tazonam; Vfend
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Belgium on 2012-08-10
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-09
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Ciprofloxacin HCL; Temazepam; Lisinopril; Fluconazole; Colistin
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-07
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Multi-Organ Failure, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Sepsis, Lung Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Haematological Malignancy
Start date: 2012-01-21
End date: 2012-01-23
Clofarabine
Dosage: 18 mg (10mg/m2), unk
Start date: 2012-01-18
End date: 2012-01-22
Clofarabine
Dosage: 19.5 mg x 1, day 1-5
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-20
Cytarabine
Dosage: 390 mg x 1, day 1-7
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-22
Cytarabine
Dosage: 1800 mg x2
Start date: 2012-01-18
End date: 2012-01-23
Idarubicin HCL
Dosage: 24 mg x 1, day 1-3
Indication: Haematological Malignancy
Start date: 2011-11-16
End date: 2011-11-18
Other drugs received by patient: Valaciclovir; Propofol; Amphotericin B; Valaciclovir
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in male
Reported by a physician from Belgium on 2012-08-06
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 65 year old male
Reported by a physician from France on 2012-08-06
Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Oedema Peripheral, Pancytopenia, Blood Creatinine Increased, Generalised Oedema, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: continuous infusion w/syringe driver 775 mg/day-day 2 to 5
Indication: Bone Marrow Conditioning Regimen
Etoposide
Dosage: 380 mg from day 2 to day 5
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Rituximab
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Treanda
Dosage: 200 mg/kg daily; day 1 and 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-05
Other drugs received by patient: Melphalan Hydrochloride
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-06
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-03
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-02
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-01
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Malaise, Diarrhoea, Pyrexia, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 210 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-26
Possible Cytarabine side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)
Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-17
End date: 2012-04-23
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-02
End date: 2012-04-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-05-06
End date: 2012-05-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Infection Prophylaxis
Start date: 2012-05-06
End date: 2012-05-08
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-05-06
End date: 2012-05-07
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-04-09
End date: 2012-04-10
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-09
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-08
End date: 2012-04-08
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-05-20
End date: 2012-05-22
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-03-29
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-06-02
End date: 2012-06-05
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-20
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-05
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-01
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-16
Imipenem and Cilastatin
Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-07
End date: 2012-05-28
Penicillin G
Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-04
End date: 2012-05-09
Vancomycin
Indication: Product Used FOR Unknown Indication
Voriconazole
Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-08
End date: 2012-05-08
Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa
Possible Cytarabine side effects in 66 year old male
Reported by a physician from United States on 2012-07-31
Patient: 66 year old male
Reactions: Sepsis, Melaena, Renal Failure Acute, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3360 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
Daunorubicin HCL
Dosage: 435 mg, (total)
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
Sprycel
Dosage: 1200 mg, (total)
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-24
End date: 2012-06-12
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-07-30
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-06-15
Daunorubicin HCL
Start date: 2012-06-15
Revlimid
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Other drugs received by patient: Fluconazole; Ciprofloxacin HCL; Temazepam; Lisinopril; Colistin
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-30
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-01
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-27
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in 17 year old male
Reported by a physician from United States on 2012-07-26
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Page 1 Next >>
|
